Abstract
It is estimated that 66% of all adult Americans are overweight or obese (1). Furthermore, 4.8% are extremely (morbidly) obese, which is defined as a body mass index (BMI) greater than or equal to 40. Calculations suggest that the number of extremely obese adults in the United States has reached a staggering 14 to 16 million people. These individuals suffer from a wide range of comorbidities and make up the second largest group of preventable deaths after smoking (>300,000 yearly) (2). The cost of treating the obese is staggering, at approximately $70 billion yearly (3). The impact of obesity is also not limited to the United States but is spreading worldwide. Globally, the prevalence of overweight/obesity was recently estimated at 1.7 billion people (4). This accounts for over 2.5 million deaths per year (5). Not far behind obesity in adults is the growing epidemic of overweight adolescents. Currently, surgery is rarely offered to these patients for fear of operative complications and longterm noncompliance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006;295(13):1549–1555.
Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76–79.
Colditz GA. Economic costs of obesity and inactivity. Med Sports 1999;31:S663–S667.
Deitel M. Overweight and obesity worldwide now estimated at 1.7 billion people. Obes Surg 2003;13:329–330.
World Health Report 2002. www.iotf.org.
Schauer P, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000;232:515–529.
Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339–352.
Dixon JB, O’Brien P. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable silicone gastric banding. Diab Care 2002;25:358–363.
Chen JDZ, McCallum RW, ed. Electrogastrography: Principles and Applications. New York: Raven, 1995.
Qian LW, Pasricha PJ, Chen JDZ. Origins and patterns of spontaneous and drug-induced canine gastric myoelectrical dysrhythmia. Dig Dis Sci 2003;48;508–515.
Hasler WL. The physiology of gastric motility and gastric emptying. In: Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE, eds. Textbook of Gastroenterology, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 1995:181–206.
Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterology 2000;95: 1456–1462.
Phillips RJ, Powley TL. Gastric volume rather than nutrient content inhibits food intake. Am J Physiol 1996;271:R766–R779.
Duggan JP, Booth DA. Obesity, overeating, and rapid gastric emptying in rats with ventromedial hypothalamic lesions. Science 1986;231:609–611.
Wright RA, Krinsky S, Fleeman C, et al. Gastric emptying and obesity. Gastroenterology 1983;84:747–751.
Carlson AJ. The Control of Hunger in Health and Disease (Psychic Secretion in Man). Chicago: University of Chicago Press, 1916.
Moran TH, McHugh PR. Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am J Physiol 1982;242:R491–R497.
Sheldon RJ, Qi JA, Porreca F, et al. Gastrointestinal motor effects of corticotropic-releasing factor in mice. Regul Pept 1990;28:137–151.
Asakawa A, Inui A, Ueno N, et al. Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology 1999;116:1287–1292.
Kelly KA. Differential responses of the canine gastric corpus and antrum to electrical stimulation. Am J Physiol 1974;226:230–234.
Miedema BW, Sarr MG, Kelly KA. Pacing the human stomach. Surgery 1992;111:143–150.
Lin ZY, McCallum RW, Schirmer BD, et al. Effects of pacing parameters in the entrainment of gastric slow waves in patients with gastroparesis. Am J Physiol (Gastrointes Liver Physiol) 1998;37:G186–G191.
Eagon JC, Kelly KA. Effects of gastric pacing on canine gastric motility and emptying. Am J Physiol 1993;265: G767–G774.
Hocking MP, Vogel SB, Sninsky CA. Human gastric myoelectrical activity and gastric emptying following gastric surgery and with pacing. Gastroenterology 1992;103:1811–1816.
Lin XM, Peters LJ, Hayes J, et al. Entrainment of segmental small intestinal slow waves with electrical stimulation in dogs. Dig Dis Sci 2000;45:652–656.
McCallum RW, Chen JDZ, Lin ZY, et al. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology 1998;114:456–461.
Qian LW, Lin XM, Chen JDZ. Normalization of atropineinduced postprandial dysrhythmias with gastric pacing. Am J Physiol (Gastrointest Liver Physiol 39) 1999;276:G387–G392.
Abo M, Liang J, Qian LW, et al. Normalization of distention-induced intestinal dysrhythmia with intestinal pacing in dogs. Dig Dis Sci 2000;45:129–135.
Bellahsene BE, Lind CD, Schlimer BD, et al. Acceleration of gastric emptying with electrical stimulation in canine model of gastroparesis. Am J Physiol 1992;262:G826–G834.
Familoni BO, Abell TL, Voeller G, et al. Electrical stimulation at a frequency higher than usual rate in human stomach. Dig Dis Sci 1997;42:885–891.
Hocking MP. Postoperative gastroparesis and tachygastriaresponse to electrical stimulation and erythromycin. Surgery 1993;114:538–542.
Xing JH, Brody F, Brodsky J, et al. Gastric electrical stimulation at proximal stomach induces gastric relaxation in dogs. Neurogastroenterol Motil 2003;15:15–23.
Cigaina V, Saggioro A, Rigo V, et al. Long-term effects of gastric pacing to reduce feed intake in swine. Obes Surg 1996;6:250–253.
Cigaina V. Gastric peristalsis control by mono situ electrical stimulation: a preliminary study. Obes Surg 1996;6: 247–249.
Cigaina V, Rigo V, Greenstein RJ. Gastric myo-electrical pacing as therapy for morbid obesity: Preliminary results. Obes Surg 1999;9:333.
Cigaina V. Gastric pacing as therapy for morbid obesity: Preliminary results. Obes Surg 2002;12:12S–16S.
Miller K, Hoeller E, Aigner F. The implantable gastric stimulator for obesity: an update of the European Experience in the LOSS (Laparoscopic Obesity Stimulation Survey) Study. Treat Endocrinol 2006;5(1):53–58.
Shikora SA, Knox TA, Bailen L, et al. Successful use of endoscopic ultrasound (EU) to verify lead placement for the implantable gastric stimulator (IGSTM). Obes Surg 2001;11:403.
Cigaina V, Hirshberg A. Gastric pacing for morbid obesity: Plasma levels of gastrointestinal peptides and leptin. Obes Res 2003;11:1456–1462.
Knippig C, Wolff S, Weigt H, et al. Gastric pacing has a positive effect on gastrointestinal reflux disease. Obes Surg 2002;12:473.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Shikora, S. (2007). Alternative Minimally Invasive Options: Gastric Pacing. In: Schauer, P.R., Schirmer, B.D., Brethauer, S.A. (eds) Minimally Invasive Bariatric Surgery. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68062-0_44
Download citation
DOI: https://doi.org/10.1007/978-0-387-68062-0_44
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-68058-3
Online ISBN: 978-0-387-68062-0
eBook Packages: MedicineMedicine (R0)